The influence of neoadjuvant chemotherapy on breast conserving therapy and post-mastectomy radiation therapy

被引：0

作者：

Zellars R.C. ^{[1
]}

机构：

[1] Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD 21231

来源：

Current Breast Cancer Reports | 2011年 / 3卷 / 4期

关键词：

Breast cancer; Breast conserving therapy; Neoadjuvant chemotherapy; Post-mastectomy; Pre-operative chemotherapy; Primary chemotherapy; Radiation therapy;

D O I：

10.1007/s12609-011-0058-0

中图分类号：

学科分类号：

摘要：

Neoadjuvant chemotherapy (NACT) has revolutionized the management of women with locally advanced breast cancer. Although this change in treatment paradigm has facilitated surgery and helped to predict outcomes in certain subsets of patients, it has also caused some confusion with respect to the role of adjuvant radiation therapy. This review discusses the benefits of NACT, the questions that arose as a result of this change in sequence, and, using the current literature, the possible answers to these questions. The reader should leave this review with a basic understanding of the issues faced by the radiation oncologist when consulting patients who have been treated with NACT. © 2011 Springer Science+Business Media, LLC.

引用

页码：220 / 224

页数：4

共 24 条

[1]

Mauri D., Pavlidis N., Jpa I., Neoadjuvant versus adjuvant systemic treatment in breast cancer: A meta-analysis, J Nat Ca i, 97, 3, (2005)

[2]

Van Der Hage J.H., Van Der Velde C.C., Sjsd M., Preoperative chemotherapy for women with operable breast cancer (Review), Cochrane Systemic Rev., (2009)

[3]

Zellars R., Post mastectomy radiation therapy, Clin Adv Hematol Oncol, 7, 8, pp. 533-49, (2009)

[4]

Lichter A.S., Lippman M.E., Danforth Jr. D.N., D'Angelo T., Steinberg S.M., Demoss E., Et al., Mastectomy versus breast-conserving therapy in the treatment of stage i and II carcinoma of the breast: A randomized trial at the National Cancer Institute, J Clin Oncol., 10, 6, pp. 976-83, (1992)

[5]

Veronesi U., Cascinelli N., Mariani L., Greco M., Saccozzi R., Luini A., Aguilar M., Marubini E., Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer, New England Journal of Medicine, 347, 16, pp. 1227-1232, (2002)

[6]

Fisher B., Bryant J., Wolmark N., Mamounas E., Brown A., Fisher E.R., Wickerham D.L., Begovic M., DeCillis A., Robidoux A., Margolese R.G., Cruz Jr. A.B., Hoehn J.L., Lees A.W., Dimitrov N.V., Bear H.D., Effect of preoperative chemotherapy on the outcome of women with operable breast cancer, Journal of Clinical Oncology, 16, 8, pp. 2672-2685, (1998)

[7]

Van Der Hage J.A., Van De Velde C.J.H., Julien J.-P., Tubiana-Hulin M., Vandervelden C., Duchateau L., Preoperative chemotherapy in primary operable breast cancer: Results from the European Organization for Research and Treatment of Cancer Trial 10902, Journal of Clinical Oncology, 19, 22, pp. 4224-4237, (2001)

[8]

Fitzal F., Riedl O., Mittlbock M., Dubsky P., Bartsch R., Steger G., Et al., Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: A retrospective single centre cohort study, Breast Cancer Res Treat, 127, pp. 121-8, (2011)

[9]

Daveau C., Savignon A., Abrous-Anane S., Pierga J.Y., Reyal F., Gautier C., Et al., Is radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?, Int J Radiation Oncology Biol Phys, 79, 5, pp. 1452-9, (2011)

[10]

Alm El-Din M., Taghian A., Breast Conservation Therapy for Patients with locally advanced breast cancer, Seminars in Rad Onc, 19, pp. 229-35, (2009)

← 1 2 3 →